KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 227 filers reported holding KITE PHARMA INC in Q2 2017. The put-call ratio across all filers is 0.38 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $18,000 | +28.6% | 177 | 0.0% | 0.00% | – |
| Q1 2017 | $14,000 | +100.0% | 177 | +22.1% | 0.00% | – |
| Q4 2016 | $7,000 | 0.0% | 145 | +8.2% | 0.00% | – |
| Q3 2016 | $7,000 | 0.0% | 134 | 0.0% | 0.00% | – |
| Q2 2016 | $7,000 | +133.3% | 134 | +143.6% | 0.00% | – |
| Q1 2016 | $3,000 | -57.1% | 55 | -54.2% | 0.00% | – |
| Q2 2015 | $7,000 | – | 120 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|